ArticleGlobal health & medicine2025
Coronary artery stenosis in Japanese hemophiliacs living with HIV-1 progressed dramatically over two years.
Article in Global health & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with hemophilia living with HIV-1 are at increased risk for coronary artery disease (CAD) due to overlapping factors, including chronic vascular inflammation, antiretroviral therapy-associated dyslipidemia, and reduced physical activity from hemophilic arthropathy. However, longitudinal data on cardiovascular outcomes in this population have been scarce. In this two-year longitudinal follow-up study, 58 patients were evaluated. The cohort was stratified into three groups based on baseline CCTA findings and treatment history: 47 with normal-to-mild stenosis, 3 with prior PCI or CABG, and 8 with moderate-to-severe stenosis. Among the moderate stenosis group, 7 underwent repeat CCTA, and 4 showed progression of coronary lesions. Of these, 3 developed severe stenosis requiring percutaneous coronary intervention (PCI), despite improvement in LDL-C through pharmacologic and lifestyle interventions. Overall, LDL-C significantly decreased (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.